Nexien Biopharma Stock Market Value

NXEN Stock  USD 0.01  0.01  30.00%   
Nexien Biopharma's market value is the price at which a share of Nexien Biopharma trades on a public exchange. It measures the collective expectations of Nexien Biopharma investors about its performance. Nexien Biopharma is selling at 0.014 as of the 4th of December 2024; that is 30 percent decrease since the beginning of the trading day. The stock's open price was 0.02.
With this module, you can estimate the performance of a buy and hold strategy of Nexien Biopharma and determine expected loss or profit from investing in Nexien Biopharma over a given investment horizon. Check out Nexien Biopharma Correlation, Nexien Biopharma Volatility and Nexien Biopharma Alpha and Beta module to complement your research on Nexien Biopharma.
Symbol

Please note, there is a significant difference between Nexien Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nexien Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nexien Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Nexien Biopharma 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nexien Biopharma's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nexien Biopharma.
0.00
11/04/2024
No Change 0.00  0.0 
In 31 days
12/04/2024
0.00
If you would invest  0.00  in Nexien Biopharma on November 4, 2024 and sell it all today you would earn a total of 0.00 from holding Nexien Biopharma or generate 0.0% return on investment in Nexien Biopharma over 30 days. Nexien BioPharma, Inc. operates as a pharmaceutical company More

Nexien Biopharma Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nexien Biopharma's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nexien Biopharma upside and downside potential and time the market with a certain degree of confidence.

Nexien Biopharma Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nexien Biopharma's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nexien Biopharma's standard deviation. In reality, there are many statistical measures that can use Nexien Biopharma historical prices to predict the future Nexien Biopharma's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nexien Biopharma's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.0134.99
Details
Intrinsic
Valuation
LowRealHigh
0.000.0134.99
Details
Naive
Forecast
LowNextHigh
0.00050.0235.01
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.010.020.02
Details

Nexien Biopharma Backtested Returns

Nexien Biopharma is out of control given 3 months investment horizon. Nexien Biopharma has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14% return per unit of risk over the last 3 months. We were able to analyze and collect data for twenty-seven different technical indicators, which can help you to evaluate if expected returns of 4.79% are justified by taking the suggested risk. Use Nexien Biopharma Risk Adjusted Performance of 0.11, mean deviation of 19.95, and Downside Deviation of 38.08 to evaluate company specific risk that cannot be diversified away. Nexien Biopharma holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of 3.63, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Nexien Biopharma will likely underperform. Use Nexien Biopharma treynor ratio, semi variance, as well as the relationship between the Semi Variance and rate of daily change , to analyze future returns on Nexien Biopharma.

Auto-correlation

    
  -0.19  

Insignificant reverse predictability

Nexien Biopharma has insignificant reverse predictability. Overlapping area represents the amount of predictability between Nexien Biopharma time series from 4th of November 2024 to 19th of November 2024 and 19th of November 2024 to 4th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nexien Biopharma price movement. The serial correlation of -0.19 indicates that over 19.0% of current Nexien Biopharma price fluctuation can be explain by its past prices.
Correlation Coefficient-0.19
Spearman Rank Test0.4
Residual Average0.0
Price Variance0.0

Nexien Biopharma lagged returns against current returns

Autocorrelation, which is Nexien Biopharma pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nexien Biopharma's pink sheet expected returns. We can calculate the autocorrelation of Nexien Biopharma returns to help us make a trade decision. For example, suppose you find that Nexien Biopharma has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Nexien Biopharma regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nexien Biopharma pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nexien Biopharma pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nexien Biopharma pink sheet over time.
   Current vs Lagged Prices   
       Timeline  

Nexien Biopharma Lagged Returns

When evaluating Nexien Biopharma's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nexien Biopharma pink sheet have on its future price. Nexien Biopharma autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nexien Biopharma autocorrelation shows the relationship between Nexien Biopharma pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Nexien Biopharma.
   Regressed Prices   
       Timeline  

Pair Trading with Nexien Biopharma

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Nexien Biopharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexien Biopharma will appreciate offsetting losses from the drop in the long position's value.

Moving against Nexien Pink Sheet

  0.38LPCUF Lees PharmaceuticalPairCorr
  0.37BRK-A Berkshire HathawayPairCorr
  0.37BRK-B Berkshire HathawayPairCorr
The ability to find closely correlated positions to Nexien Biopharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Nexien Biopharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Nexien Biopharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Nexien Biopharma to buy it.
The correlation of Nexien Biopharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Nexien Biopharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Nexien Biopharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Nexien Biopharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Other Information on Investing in Nexien Pink Sheet

Nexien Biopharma financial ratios help investors to determine whether Nexien Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nexien with respect to the benefits of owning Nexien Biopharma security.